Home/Latigo Biotherapeutics/Neil Singla, M.D.
NS

Neil Singla, M.D.

Chief Medical Officer

Latigo Biotherapeutics

Therapeutic Areas

Latigo Biotherapeutics Pipeline

DrugIndicationPhase
LTG-001Pain (specific type not disclosed)Phase 1